BridgeMD
New treatment option for Endometrial Cancer
Official title Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.
ClinicalTrials.gov ID: NCT07025213
What this study is testing
- What it's testing
- Background: Endometrial cancer is one of the diseases linked to obesity in women. In Mexico, about 7.6 women out of every 100,000 are diagnosed with this type of cancer, and nearly three-quarters of these women have obesity.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, women only
You may be able to join if
- -Ability to understand the nature of the study and provide written informed consent.
- -Women aged over 18 and under 65 years.
- -Availability to attend exercise sessions.
- -Willingness and ability to comply with scheduled visits, the proposed nutritional algorithm, treatment plan, and laboratory tests.
- -Histologically confirmed diagnosis of endometrioid-type endometrial cancer by biopsy.
You likely can't join if
- -Patients with advanced clinical stage or stage IVB disease (according to FIGO 2018 criteria).
- -Patients with a prior or concurrent malignancy, except non-melanoma skin cancer.
- -Patients with uncontrolled systemic arterial hypertension.
- -Patients with renal dysfunction (eGFR ≤ 60 mL/min/1.73 m²).
- -Patients with uncontrolled psychiatric disorders, including claustrophobia.
- -Patients with concurrent infections.
See the full eligibility criteria
- -Ability to understand the nature of the study and provide written informed consent.
- -Women aged over 18 and under 65 years.
- -Availability to attend exercise sessions.
- -Willingness and ability to comply with scheduled visits, the proposed nutritional algorithm, treatment plan, and laboratory tests.
- -Histologically confirmed diagnosis of endometrioid-type endometrial cancer by biopsy.
- -Normal electrocardiogram (ECG) result.
- -No prior oncological treatment.
- -Body mass index (BMI) greater than 20 kg/m².
- -Availability of a computed tomography (CT) scan.
- -Candidates for staging surgery.
- -Patients with advanced clinical stage or stage IVB disease (according to FIGO 2018 criteria).
- -Patients with a prior or concurrent malignancy, except non-melanoma skin cancer.
- -Patients with uncontrolled systemic arterial hypertension.
- -Patients with renal dysfunction (eGFR ≤ 60 mL/min/1.73 m²).
- -Patients with uncontrolled psychiatric disorders, including claustrophobia.
- -Patients with concurrent infections.
- -Patients with autoimmune disease.
- -Patients with neuromuscular disease.
- -Contraindications to physical exercise.
- -Vulnerable situations (e.g., homelessness preventing adherence to diet, or incarceration).
The study team makes the final eligibility decision.
Where it's taking place
- México, Tlalpan, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include México, Tlalpan, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.